神経芽細胞腫：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Neuroblastoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Neuroblastoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Neuroblastoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Neuroblastoma 24
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Neuroblastoma Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Neuroblastoma 34
Aug 13, 2013: Cancer Research UK launches international trial for treatment of relapsed neuroblastoma 34
Jun 21, 2012: Aeterna Zentaris Announces Phase I Results Of Perifosine Show Activity Against Neuroblastoma 34
Jun 21, 2012: Cleveland BioLabs And Incuron Announce Results Of Studies Of CBL0137 In Animal Models Of Neuroblastoma 35
Jun 13, 2012: Aeterna Zentaris To Present Phase I Results Of Perifosine In Neuroblastoma At Upcoming Neuroblastoma Research Conference 36
Jun 12, 2012: Study Unveils Combination Of Radioactive Isotope With Chemotherapy Has Potential To Treat 36
Neuroblastoma 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Progenics Pharmaceuticals, Inc. 38
Clinical Trial Overview of Progenics Pharmaceuticals, Inc. 38
F. Hoffmann-La Roche Ltd. 39
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 39
APEIRON Biologics AG 40
Clinical Trial Overview of APEIRON Biologics AG 40
United Therapeutics Corporation 41
Clinical Trial Overview of United Therapeutics Corporation 41
Cancer Prevention Pharmaceuticals, Inc. 42
Clinical Trial Overview of Cancer Prevention Pharmaceuticals, Inc. 42
MabVax Therapeutics, Inc. 43
Clinical Trial Overview of MabVax Therapeutics, Inc. 43
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
Celgene Corporation 45
Clinical Trial Overview of Celgene Corporation 45
Biotec Pharmacon ASA 46
Clinical Trial Overview of Biotec Pharmacon ASA 46
Clinical Trial Overview of Top Institutes / Government 47
National Cancer Institute 47
Clinical Trial Overview of National Cancer Institute 47
Children’s Oncology Group 53
Clinical Trial Overview of Children’s Oncology Group 53
Memorial Sloan Kettering Cancer Center 56
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 56
Children’s Cancer and Leukaemia Group 59
Clinical Trial Overview of Children’s Cancer and Leukaemia Group 59
Baylor College of Medicine 61
Clinical Trial Overview of Baylor College of Medicine 61
Fred Hutchinson Cancer Research Center 62
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 62
New Approaches to Neuroblastoma Therapy 63
Clinical Trial Overview of New Approaches to Neuroblastoma Therapy 63
The Children’s Hospital Los Angeles 64
Clinical Trial Overview of The Children’s Hospital Los Angeles 64
Japan Neuroblastoma study group 65
Clinical Trial Overview of Japan Neuroblastoma study group 65
Five Key Clinical Profiles 66
Appendix 144
Abbreviations 144
Definitions 144
Research Methodology 145
Secondary Research 145
About GlobalData 146
Contact Us 146
Disclaimer 146
Source 147